PharmEasy-Owned Thyrocare’s Q3 Profit Jumps 29% To INR 19 Cr

PharmEasy-owned Thyrocare reported a 29% increase in its Q3 profit, reaching INR 19 crore. This growth is attributed to the rise in demand for healthcare services, including diagnostic tests. The company has focused on expanding its service offerings and increasing its customer base. Thyrocare's robust financial performance in the third quarter highlights its strong market presence in the healthcare sector, driven by a combination of strategic expansions, cost control measures, and increased demand for its diagnostic services. The company is now looking to leverage its growth momentum to continue expanding its reach in the healthcare market.